Initiation of pharmacological treatment in Parkinson’s disease in the UK: A Clinical Practice Research Datalink retrospective study
2013 Journal of the neurological sciences
Bineau, S. | Guelfucci, F. | Neine, M.E. | Aballea, S. | Milea, D. |
Issue: suppl 1,
database analysis, Parkinson Disease, Retrospective Studies, united kingdom,
In UK guidelines, levodopa (LD), dopamine agonists (DA) and monoamine-oxidase-B (MAO-B) inhibitors are recommended as initial options for the pharmacological treatment of Parkinson’s disease (PD). The choice for these treatments should take into account patient clinical profile, lifestyle characteristics and patient preferences.